Bile acids in metabolic dysfunction-associated steatotic liver disease

doi:10.4254/wjh.v17.i8.108606

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1016)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

HTML

732

Figures (1-3)

Sum=820

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=164

Aug 27, 2025 (publication date) through Sep 2, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Aug 27, 2025; 17(8): 108606
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108606

Full Size Figure Download Figure

Figure 3 Multifactorial interplay of bile acids, metabolic dysregulation, gut microbiota, inflammation, and fibrosis in metabolic dysfunction-associated steatotic liver disease pathogenesis. FXR: Farnesoid X receptor; TGR5: Takeda G-protein-coupled receptor 5.

Citation: Zerem E, Kunosic S, Kurtcehajic A, Zerem D, Zerem O. Bile acids in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(8): 108606
URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108606.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108606